Q13451 (FKBP5_HUMAN) Homo sapiens (Human)
Peptidyl-prolyl cis-trans isomerase FKBP5 UniProtKBInterProSTRINGInteractive Modelling
457 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
97 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human FKBP51 protein in complex with C-terminal peptide of Human HSP 90-alpha |
Heteromer Q96HX7; | 100 | 3×SO4; | |||
| Cryo-EM structure of the GR-Hsp90-FKBP51 complex |
Heteromer P04150; P07900; | 100 | 2×ATP; 2×MG; 1×DEX; | |||
| Cryo-EM structure of Hsp90:FKBP51:p23 closed-state complex |
Heteromer P07900; Q15185; | 100 | 2×ANP; | |||
| Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR at low … |
Heteromer P42345; | 100 | 1×RAP; 11×SO4; | |||
| Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR |
Heteromer P42345; | 100 | 1×RAP; | |||
| SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC |
Heteromer P40337; Q15369; Q15370; | 98.33 | 1×XZW; | |||
| The Fk1 domain of FKBP51 in complex with (2S)-2-((1S,5R,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo… | homo-2-mer | 99.2 | 2×RR5; | |||
| Human FKBP5 protein | monomer | 100 | 3×SO4; | |||
| Structure of the Large FKBP-like Protein, FKBP51, Involved in Steroid Receptor Complexes | monomer | 99.72 | 3×SO4; | |||
| Crystal structure of a fragment of FKBP51 comprising the Fk1 and Fk2 domains | monomer | 100 | ||||
| Fk1 domain of FKBP51, crystal form VI | monomer | 100 | ||||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymet… | monomer | 99.2 | 1×RSB; | |||
| The Fk1 domain of FKBP51 in complex with Antascomicine B | monomer | 99.2 | 1×Y6Z; | |||
| Fk1 domain mutant A19T of FKBP51, crystal form IV, in presence of DMSO | monomer | 99.2 | 2×DMS; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH NICOTINAMIDE | monomer | 99.2 | 1×CL; 2×NA; 2×NCA; | |||
| The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(p… | monomer | 97.6 | 1×UUI; | |||
| Exploration of Pipecolate Sulfonamides as Binders of the FK506-Binding Proteins 51 and 52: Complex … | monomer | 99.2 | 1×0OS; | |||
| The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfinyl)-3-(pyridi… | monomer | 97.6 | 1×UT6; | |||
| Fk1 domain mutant A19T of FKBP51, crystal form IV | monomer | 99.2 | ||||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-5-(hydroxymet… | monomer | 99.2 | 1×9QN; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.2 | 1×1KZ; | |||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-(2-methoxye… | monomer | 99.2 | 1×384; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PYRIDONE | monomer | 99.2 | 1×CL; 2×NA; 2×HRZ; | |||
| EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[… | monomer | 99.2 | 1×0MC; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.2 | 1×1KU; | |||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-3-[2-(3,4-dim… | monomer | 99.2 | 1×3JP; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 4-METHYLIMIDAZOLE | monomer | 99.2 | 2×NA; 1×4MZ; | |||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymet… | monomer | 99.2 | 1×RQW; | |||
| The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((R)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(p… | monomer | 97.6 | 1×UUI; | |||
| EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH (1R)… | monomer | 99.2 | 1×0MD; | |||
| Complex of Fk506 with the Fk1 domain mutant A19T of FKBP51 | monomer | 99.2 | 1×FK5; | |||
| Structure of the FK1 domain of the FKBP51 G64S variant in complex with SAFit1 | monomer | 96.8 | 1×GY1; 1×EPE; 2×GOL; | |||
| Structure of the FK1 domain of the FKBP51 G64S variant in complex with (2R,5S,12R)-12-cyclohexyl-2-… | monomer | 96.8 | 1×S8N; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PIPERIDONE | monomer | 99.2 | 1×CL; 2×NA; 2×V1L; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 63 | monomer | 97.6 | 1×T5H; | |||
| Fk1 domain mutant A19T of FKBP51, crystal form III | monomer | 99.2 | 1×SCN; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.2 | 1×JFK; | |||
| The Fk1 domain of FKBP51 in complex with (2'R,5'S,12'R)-12'-cyclohexyl-2'-[2-(3,4-dimethoxyphenyl)e… | monomer | 99.2 | 1×RTT; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH IMIDAZOLE | monomer | 99.2 | 1×CL; 2×NA; 1×IMD; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.2 | 1×1KY; | |||
| The Fk1 domain of FKBP51 in complex with iFit4 | monomer | 99.2 | 1×37K; | |||
| The Fk1 domain of FKBP51 in complex with the new synthetic ligand 2-(3-((R)-1-((S)-1-((S)-2-cyclohe… | monomer | 99.2 | 1×5BG; | |||
| Fk1 domain mutant A19T of FKBP51, crystal form I | monomer | 99.2 | 1×1PE; | |||
| The FK1 domain of FKBP51 in complex with peptide-inhibitor hit DFPFV | monomer | 99.2 | ||||
| The Fk1 domain of FKBP51 in complex with SAFit1 | monomer | 97.6 | 1×GY1; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 64a | monomer | 97.6 | 1×T5B; | |||
| The Fk1 domain of FKBP51 in complex with iFit1 | monomer | 99.2 | 1×37L; 1×GOL; 1×NA; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH HYDANTOIN | monomer | 99.2 | 1×HYN; 2×NA; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 35-(E) | monomer | 97.6 | 1×T58; 3×IS8; | |||
| EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[… | monomer | 99.2 | 1×0MC; | |||
| EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[… | monomer | 99.2 | 1×I63; | |||
| FKBP51FK1 F67E/K60Orn (i, i+7) in complex with SAFit1 | monomer | 94.4 | 1×GY1; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)propanoy… | monomer | 97.6 | 1×UCT; | |||
| FKBP51FK1 F67E/K58 (i, i+9) in complex with SAFit1 | monomer | 95.2 | 1×GY1; | |||
| Fk1 domain of FKBP51, crystal form VII | monomer | 100 | 1×CO3; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((1R)-1-(((2S)-1-(2-(5-chlorothiophen-2-yl)-2-cyclohe… | monomer | 97.6 | 1×U83; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((1R)-1-(((2S)-1-(2-cyclohexyl-2-(thiophen-2-yl)acety… | monomer | 97.6 | 1×U8C; | |||
| Evaluation of Synthetic FK506 Analogs as Ligands for the FK506-Binding Proteins 51 and 52: Complex … | monomer | 99.2 | 1×0MD; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 15i | monomer | 97.6 | 1×A1H7C; | |||
| Fk1 domain of FKBP51, crystal form II | monomer | 100 | ||||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 33-(Z) | monomer | 97.6 | 1×R3E; | |||
| Fk1 domain of FKBP51, crystal form I | monomer | 100 | ||||
| The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)pent-4-e… | monomer | 97.6 | 1×UC0; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23a | monomer | 97.6 | 1×A1H68; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 24e | monomer | 97.6 | 1×A1H7E; | |||
| The Fk1 domain of FKBP51 in complex with (S)-(R)-3-(3,4-dimethoxyphenyl)-1-(3-(2-morpholinoethoxy)p… | monomer | 99.2 | 1×L2Q; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)-2-(3,4,… | monomer | 97.6 | 1×UCO; | |||
| CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH SAFit2 | monomer | 99.2 | 1×37K; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 15b | monomer | 97.6 | 1×A1H7A; | |||
| The Fk1 domain of FKBP51 in complex with the new synthetic ligand (1R)-3-(3,4-dimethoxyphenyl)-1-f3… | monomer | 99.2 | 1×5B8; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 15h | monomer | 97.6 | 1×A1H7B; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23b | monomer | 97.52 | 1×A1H7F; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23d | monomer | 97.6 | 1×A1H7D; | |||
| The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]… | monomer | 99.19 | 1×RTQ; | |||
| The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-3,5-dichloro-N-methylphenylsulfonimidoy… | monomer | 97.58 | 1×UMR; | |||
| Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational … | monomer | 99.19 | 1×1KT; 1×DMS; 1×GOL; | |||
| The Fk1 domain of FKBP51 in complex with ((1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo-5-viny… | monomer | 99.19 | 1×RRZ; | |||
| The FK1 domain of FKBP51 in complex with (3S,11S,11aS)-12-((3,5-dichlorophenyl)sulfonyl)-5-oxo-11-v… | monomer | 97.58 | 1×A1H70; | |||
| The FK1 domain of FKBP51 in complex with (3S,11S)-12-((3,5-dichlorophenyl)sulfonyl)-5-oxo-11-vinyld… | monomer | 97.58 | 1×A1H78; | |||
| Structure of the FK1 domain of the FKBP51 G64S variant in complex with (1S,5S,6R)-10-((3,5-dichloro… | monomer | 96.77 | 1×9QN; | |||
| Complex of the Fk1 domain mutant A19T of FKBP51 with 4-Nitrophenol | monomer | 99.19 | 1×NPO; | |||
| The Fk1 domain of FKBP51 in complex with (2R,5S,12S)-12-(thiophen-2-yl)-2-[2-(3,4-dimethoxyphenyl)e… | monomer | 97.58 | 1×UBK; | |||
| The FK1 domain of FKBP51 in complex with peptide-inhibitor hit SFPFT | monomer | 99.19 | ||||
| The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]… | monomer | 97.58 | 1×S8N; | |||
| The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)butanoyl… | monomer | 97.5 | 1×UCF; 1×GOL; | |||
| The FK1 domain of FKBP51 in complex with peptide-inhibitor hit QFPFV | monomer | 99.19 | ||||
| Fk1 domain mutant A19T of FKBP51, crystal form II | monomer | 99.19 | ||||
| The Fk1 domain of FKBP51 in complex with the new synthetic ligand (S)-N-(1-carbamoylcyclopentyl)-1-… | monomer | 99.19 | 1×5BH; | |||
| Fk1 domain of FKBP51, crystal form III | monomer | 100 | ||||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 55 | monomer | 97.58 | 1×S5W; | |||
| Fk1 domain of FKBP51, crystal form VIII | monomer | 100 | ||||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1R)-1,2-d… | monomer | 99.19 | 1×3JQ; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23j | monomer | 97.54 | 1×A1H7U; | |||
| Allosteric coupling of conformational transitions in the FK1 domain of FKBP51 near the site of ster… | monomer | 99.17 | ||||
| The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1S)-1,2-d… | monomer | 99.17 | 1×3JR; | |||
| The FK1 domain of FKBP51 in complex with SAFit-analog 23c | monomer | 98.35 | 1×A1H7G; | |||
| Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 56 | monomer | 98.31 | 1×R3B; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5omp.1.A | monomer | 0.79 | 100.00 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3o5d.1.A | monomer | 0.77 | 95.28 | |||